News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared for the launch of its ...
By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...
This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...
A weight loss expert said that this tasty and affordable vegetable is packed with fibre, antioxidants and anti-inflammatory ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
Lizzo shed light on her go-to meals that have helped her maintain her weight loss goals amid her health journey.
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
At Lindora Weight Loss & Wellness, some of their clients have lost as much as 125 pounds. Sarah Hathor and Genia Burdick ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...
“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...